Cell No. : Cell Name
HPS0381 : 1231A3
update : 2024/09/17
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0379, HPS0380, HPS0381, HPS4293 was derived from the same person. |
| Comment from the depositor | |
| Terms and conditions | 1) In relation to the for-profit organizations, please contact iPS Academia Japan, Inc., prior to the utilization of iPS cells. 2) Attach Appendix (non-for-profit) or Appendix (for-profit) to MTA (C-0007 or C-0007p) . |
| Remarks | |
| Order Form |
Order Form(C-0042.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Yamanaka, Shinya
|
| Year of deposit |
2013
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
African/American
|
| Gender |
Female
|
| Age at sampling |
29
|
| Tissue |
peripheral blood
|
| Classification |
iPS
|
| Recombinant |
recombinant
|
|
Lifespan |
infinite
|
| Morphology |
ES-like
|
| Cellosaurus(Expasy) |
CVCL_LJ39
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
StemFit AK02N
|
| Antibiotics |
|
Free
|
|
Passage method |
|
TrypLE Select CTS : 0.5 mM EDTA/PBS(-) = 1 : 1
|
| Coating dish |
|
0.5 μg/cm 2 Laminin-511 E8 (iMatrix511)
|
Culture information
|
Passage cell No |
|
2.6-26x10 4 cells/60 mm dish
|
| SC frequency |
|
Subculture : once/5-8 days, Medium Renewal : every day or every other day
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Feeder cells |
|
Free
|
| Freeze medium |
|
StemFit AK02N + 10 μM Y-27632 + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| Virus (HIV) |
|
Undetected
|
| Virus (HTLV-1) |
|
(-)
|
| Chromosome mode |
46,XX,inv(9)(p12q13)
|
46,XX,inv(9)(p12q13) [20] at passage No. 14
|
| Others |
|
Use 10μM Y-27632 when passaging and thawing. Remove it next day.
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
2
|
| User's Publication |
16
|
| User's Publication |
|
19706
Bamba K, Ozawa M, Daitoku H, Kohara A.
Diverting the food-freezing technology improves the cryopreservation efficiency of induced pluripotent stem cells and derived neurospheres
Regen Ther
2024
27:83-91
PubMed ID: 38525239
DOI: 10.1016/j.reth.2024.03.007
|
|
21586
Oonishi T, Nishimura K, Takata K, Fujimuro M, Sekine Y.
Scraping Assay as a Novel Strategy to Evaluate Axonal Regeneration Using Human-Induced Pluripotent Stem Cell-Derived Neurons.
Biol Pharm Bull
2024
47(2):366-372
PubMed ID: 38325853
DOI: 10.1248/bpb.b23-00675
|
|
21612
Gima S, Oe K, Nishimura K, Ohgita T, Ito H, Kimura H, Saito H, Takata K.
Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons.
Regen Ther
2024
25:229-237
PubMed ID: 38283940
DOI: 10.1016/j.reth.2023.12.019
|
|
21915
Wang J, Morita K, Iwata T.
Induction of periodontal ligament-derived mesenchymal stromal cell-like cells from human induced pluripotent stem cells
Regen Ther
2024
26:432-441
PubMed ID: 39045575
DOI: 10.1016/j.reth.2024.05.005
|
|
17772
Lin W, Shiomoto S, Yamada S, Watanabe H, Kawashima Y, Eguchi Y, Muramatsu K, Sekino Y.
Dendritic spine formation and synapse maturation in transcription factor-induced human iPSC-derived neurons
iScience
2023
26(4):106285
PubMed ID: 37034988
DOI: 10.1016/j.isci.2023.106285
|
|
21050
Fukuda A, Nakashima S, Oda Y, Nishimura K, Kawashima H, Kimura H, Ohgita T, Kawashita E, Ishihara K, Hanaki A, Okazaki M, Matsuda E, Tanaka Y, Nakamura S, Matsumoto T, Akiba S, Saito H, Matsuda H, Takata K.
Plantainoside B in Bacopa monniera Binds to Aβ Aggregates Attenuating Neuronal Damage and Memory Deficits Induced by Aβ.
Biol Pharm Bull
2023
46(2):320-333
PubMed ID: 36724960
DOI: 10.1248/bpb.b22-00797
|
|
21085
Inoue S, Nishimura K, Gima S, Nakano M, Takata K.
CRISPR-Cas9-Edited SNCA Knockout Human Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons and Their Vulnerability to Neurotoxicity.
Biol Pharm Bull
2023
46(3):517-522
PubMed ID: 36858582
DOI: 10.1248/bpb.b22-00839
|
|
21123
Takata M, Nishimura K, Harada K, Iwasaki R, Ando M, Yamada S, Ginhoux F, Takata K.
Analysis of Aβ-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived cortical culture systems.
Tissue Cell
2023
81:102023
PubMed ID: 36709697
DOI: 10.1016/j.tice.2023.102023
|
|
21260
Taga S, Suga H, Nakano T, Kuwahara A, Inoshita N, Kodani Y, Nagasaki H, Sato Y, Tsumura Y, Sakakibara M, Soen M, Miwata T, Ozaki H, Kano M, Watari K, Ikeda A, Yamanaka M, Takahashi Y, Kitamoto S, Kawaguchi Y, Miyata T, Kobayashi T, Sugiyama M, Onoue T, Yasuda Y, Hagiwara D, Iwama S, Tomigahara Y, Kimura T, Arima H.
Generation and purification of ACTH-secreting hPSC-derived pituitary cells for effective transplantation.
Stem Cell Reports
2023
PubMed ID: 37295423
DOI: 10.1016/j.stemcr.2023.05.002
|
|
21294
Kato T, Nishimura K, Hirao M, Shimohama S, Takata K.
Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.
Neuropsychopharmacol Rep
2023
PubMed ID: 37366076
DOI: 10.1002/npr2.12361
|
|
21311
Kaneko H, Kaitsuka T, Tomizawa K.
Artificial induction of circadian rhythm by combining exogenous BMAL1 expression and polycomb repressive complex 2 inhibition in human induced pluripotent stem cells.
Cell Mol Life Sci
2023
80(8):200
PubMed ID: 37421441
DOI: 10.1007/s00018-023-04847-z
|
|
21322
Minami S, Matsumoto N, Omori H, Nakamura Y, Tamiya S, Nouda R, Nurdin JA, Yamasaki M, Kotaki T, Kanai Y, Okamoto T, Tachibana T, Ushijima H, Kobayashi T, Sato S.
Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells.
Sci Rep
2023
13(1):11610
PubMed ID: 37463955
DOI: 10.1038/s41598-023-38548-1
|
|
21492
Mae SI, Hattanda F, Morita H, Nozaki A, Katagiri N, Ogawa H, Teranaka K, Nishimura Y, Kudoh A, Yamanaka S, Matsuse K, Ryosaka M, Watanabe A, Soga T, Nishio S, Osafune K.
Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
Cell Rep
2023
113431
PubMed ID: 38039961
DOI: 10.1016/j.celrep.2023.113431
|
|
21522
Wu Y, Iwasaki K, Hashimoto Y.
Induction of mesenchymal stem cell (MSC) differentiation from iPS cells using MSC medium.
Dent Mater J
2023
PubMed ID: 38008439
DOI: 10.4012/dmj.2023-130
|
|
20573
Nakano Y, Susa K, Yanagi T, Hiraoka Y, Suzuki T, Mori T, Ando F, Mandai S, Fujiki T, Rai T, Uchida S, Sohara E.
Generation of NPHP1 knockout human pluripotent stem cells by a practical biallelic gene deletion strategy using CRISPR/Cas9 and ssODN.
In Vitro Cell Dev Biol Anim
2022
PubMed ID: 35165826
DOI: 10.1007/s11626-022-00655-0
|
|
16864
Kenzo BAMBA, Midori OZAWA, Miho TAMAI, Emiko SHIMBO, Hiromasa SHINDO, Takuo OTA, Sungho AHN, Arihiro KOHARA, Yoh-ichi TAGAWA
Human serum albumin-containing xeno-free freezing medium optimized for regenerative medicine
Translational and Regulatory Sciences
2021
3:77-82
DOI: 10.33611/trs.2021-008
|
Back
Top
CELL BANK Website